Will GiveWell fund Post-discharge malaria chemoprevention (PMC) for children with severe anemia by 1st January 2027? DRAFT
Main Draft >
Nathan Young's suggestion
Viewing Nathan Young's Proposed Changes
Josh Hart 13:58Reply
Nathan Young started suggesting18:25Reply
GiveWell has recommended grants to over 10 charities over the years. They are currently investigating 12 charity areas with other areas of research in the pipeline including Post-discharge malaria chemoprevention (PMC) for children with severe anemia.
**The following is taken directly from GiveWell’s explanation of the topic **
In areas with high malaria prevalence, children treated in hospitals for severe anemia may be at increased risk of death after being discharged due to new or recurrent malaria. Post-discharge malaria chemoprevention is the provision of antimalarials to these children.
The World Health Organization (WHO) does not provide post-discharge guidance in its recommendations for seasonal malaria chemoprevention (SMC) or in its guidelines for malaria. Our understanding is that WHO may be considering guidance on PMC in the near future, and we anticipate implementation opportunities will be limited until WHO provides that guidance, though we have not thoroughly investigated this.
Because of our impression that there will be limited funding opportunities, we do not plan to do further work on PMC for children with severe anemia at this time. We plan to revisit this if WHO provides updated guidance. We would also be willing to consider promising opportunities if they came to our attention in the meantime.